CARDINAL HEALTH INC
S-8, 2000-05-31
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: EUROPACIFIC GROWTH FUND, 485BPOS, EX-99.JOTHEROPININ, 2000-05-31
Next: CARDINAL HEALTH INC, S-8, EX-4.B, 2000-05-31



<PAGE>   1


            As filed with the Securities and Exchange Commission on May 31, 2000
                                                    Registration No. 333-_______

================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                 ---------------
                                    FORM S-8
                             REGISTRATION STATEMENT
                                      Under
                           The Securities Act of 1933

                                 ---------------
                              CARDINAL HEALTH, INC.
             (Exact name of registrant as specified in its charter)

            Ohio                                        31-0958666
(State or other jurisdiction of            (I.R.S. Employer Identification No.)
incorporation or organization)

 7000 Cardinal Place, Dublin, Ohio                          43017
(Address of Principal Executive Offices)                  (Zip Code)

                                 ---------------
            CARDINAL HEALTH, INC. GLOBAL EMPLOYEE STOCK PURCHASE PLAN
                            (Full title of the plan)

                                 ---------------
                               Steven Alan Bennett
           Executive Vice President, Chief Legal Officer and Secretary
                              Cardinal Health, Inc.
                               7000 Cardinal Place
                               Dublin, Ohio 43017
                     (Name and address of agent for service)

                                 (614) 757-5000
          (Telephone number, including area code, of agent for service)
                                 ---------------

                         CALCULATION OF REGISTRATION FEE

<TABLE>
<CAPTION>
=================================================================================================================================
                                                            Proposed maximum           Proposed maximum
  Title of securities to           Amount to be              offering price           aggregate offering   Amount of registration
        registered                 registered(1)              per share(2)                 price(2)                 fee(2)
---------------------------------------------------------------------------------------------------------------------------------
<S>                                  <C>                          <C>                   <C>                     <C>
Common Shares without par
value                                3,000,000                    $62.3125              $186,937,500             $49,352
=================================================================================================================================
</TABLE>

(1)  Also includes an indeterminable number of additional shares that may become
     issuable pursuant to the anti-dilution provisions of the Plans.

(2)  The registration fee has been calculated pursuant to Rule 457(c) and (h)
     based on the average of the high and low sale prices on May 23, 2000, of
     the Registrant's Common Shares as reported on the New York Stock Exchange.


<PAGE>   2


                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

ITEM 3.  INCORPORATION OF DOCUMENTS BY REFERENCE.

         The documents listed in (a) through (e) below are incorporated by
reference in the registration statement. All documents filed by the Company
pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act
of 1934, as amended (the "Exchange Act"), subsequent to the date of the filing
of this registration statement and prior to the filing of a post-effective
amendment that indicates that all securities registered hereunder have been
sold, or that de-registers all securities then remaining unsold, shall be deemed
to be incorporated by reference in the registration statement and to be a part
hereof from the date of the filing of such documents.

         (a)      The Current Report on Form 8-K of the Company filed with the
                  Securities and Exchange Commission (the "Commission") on May
                  26, 2000;

         (b)      The Annual Report on Form 10-K of the Company for the fiscal
                  year ended June 30, 1999 filed with the Commission on
                  September 2, 1999, excluding Items 6, 7, 7(a) and 8 and
                  Schedule II ("Form 10-K");

         (c)      The Quarterly Reports on Form 10-Q of the Company for the
                  fiscal quarters ended September 30, 1999 filed with the
                  Commission on November 12, 1999; December 31, 1999 filed with
                  the Commission on February 11, 2000; and March 31, 2000 filed
                  with the Commission on May 12, 2000;

         (d)      The information contained in the Company's Proxy Statement
                  dated September 21, 1999 for its Annual Meeting of
                  Shareholders held on November 3, 1999 which has been
                  incorporated by reference in its Form 10-K; and

         (e)      The description of the Company's Common Shares contained in
                  the Company's Registration Statement on Form 8-A dated August
                  19, 1994, pursuant to Section 12 of the Exchange Act.

ITEM 5.  INTERESTS OF NAMED EXPERTS AND COUNSEL.

         The legality of the Common Shares offered hereby has been passed upon
for the Company by Amy B. Haynes, Assistant General Counsel, Securities and
Corporate Governance of the Company. Ms. Haynes holds Common Shares of the
Company, as well as vested and unvested options to purchase Common Shares of the
Company, and unvested restricted Common Shares of the Company.

ITEM 6.  INDEMNIFICATION OF DIRECTORS AND OFFICERS.

         Section 1701.13(E) of the Ohio Revised Code sets forth conditions and
limitations governing the indemnification of officers, directors, and other
persons.

         Article 6 of the Company's Restated Code of Regulations ("Code of
Regulations"), as amended and restated, contains certain indemnification
provisions adopted pursuant to authority contained in Section 1701.13(E) of the
Ohio Revised Code. The Company's Code of Regulations provides for the
indemnification of its officers, directors, employees, and agents against all
expenses with respect to any judgments, fines, and amounts paid in settlement,
or with respect to any threatened, pending, or completed action, suit, or
proceeding to which they were or are parties or are threatened to be made
parties by reason of acting in such capacities, provided that it is determined,
either by a majority vote of a quorum of disinterested directors of the Company
or the shareholders of the Company or otherwise as provided in Section
1701.13(E) of the Ohio Revised Code, that (a) they acted in good faith and in a
manner they reasonably believed to be in or not opposed to the best interest of
the Company; (b) in any action, suit, or proceeding by or in the right of the
Company, they were not, and have not been adjudicated to have been, negligent or
guilty of misconduct in the performance of their duties to the Company; and (c)
with respect



                                       2
<PAGE>   3
to any criminal action or proceeding, that they had no reasonable cause to
believe that their conduct was unlawful. Section 1701.13(E) provides that to the
extent a director, officer, employee, or agent has been successful on the merits
or otherwise in defense of any such action, suit, or proceeding, such individual
shall be indemnified against expenses reasonably incurred in connection
therewith. At present there are no material claims, actions, suits, or
proceedings pending where indemnification would be required under these
provisions, and the Company does not know of any such threatened claims,
actions, suits, or proceedings which may result in a request for such
indemnification.

         The Company has entered into indemnification contracts with each of its
directors and executive officers. These contracts generally: (i) confirm the
existing indemnity provided to them under the Company's Code of Regulations and
assure that this indemnity will continue to be provided; (ii) provide that if
the Company does not maintain directors' and officers' liability insurance, the
Company will, in effect, become a self-insurer of the coverage; (iii) provide
that, in addition, the directors and officers shall be indemnified to the
fullest extent permitted by law against all expenses (including legal fees),
judgments, fines, and settlement amounts incurred by them in any action or
proceeding on account of their service as a director, officer, employee, or
agent of the Company, or at the request of the Company as a director, officer,
employee, trustee, fiduciary, manager, member or agent of another corporation,
partnership, trust, limited liability company, employee benefit plan or other
enterprise and; (iv) provide for the mandatory advancement of expenses to the
executive officer or director in connection with the defense of any proceedings,
provided that the executive officer or director agrees to reimburse the Company
for that advancement if it is ultimately determined that the executive officer
or director is not entitled to the indemnification for that proceeding under the
agreement. Coverage under the contracts is excluded: (A) on account of conduct
which is finally adjudged to be knowingly fraudulent, deliberately dishonest, or
willful misconduct; or (B) if a final court of adjudication shall determine that
such indemnification is not lawful; or (C) in respect of any suit in which
judgment is rendered for violations of Section 16(b) of the Securities and
Exchange Act of 1934, as amended, or provisions of any federal, state, or local
statutory law; or (D) on account of any remuneration paid which is finally
adjudged to have been in violation of law; or (E) on account of conduct
occurring prior to the time the executive officer or director became an officer,
director, employee or agent of the Company or its subsidiaries (but in no event
earlier than the time such entity became a subsidiary of Cardinal); or (F) with
respect to proceedings initiated or brought voluntarily by the executive officer
or director and not by way of defense, except for proceedings brought to enforce
rights under the indemnification contract.

         The Company maintains a directors' and officers' insurance policy which
insures the officers and directors of the Company from any claim arising out of
an alleged wrongful act by such persons in their respective capacities as
officers and directors of the Company.

ITEM 8.  EXHIBITS.

Exhibit Number    Description of Exhibit
--------------    ----------------------

4(a)              Specimen Certificate for the Registrant's Class A Common
                  Shares(1)

4(b)              Cardinal Health, Inc. Global Employee Stock Purchase Plan

5                 Opinion of Amy B. Haynes as to legality of the Common
                  Shares being registered

23(a)             Consent of Deloitte & Touche LLP

23(b)             Consent of PricewaterhouseCoopers LLP

23(c)             Consent of Arthur Andersen LLP

23(d)             Consent of Amy B. Haynes (included in Opinion filed as
                  Exhibit 5 hereto)

24                Power of Attorney (included in signature page to Registration
                  Statement)

(1) Included as an exhibit to the Registrant's Registration Statement on Form
S-4 (No. 333-74761) and incorporated herein by reference.


                                       3
<PAGE>   4
ITEM 9.  UNDERTAKINGS.

A.     The undersigned Registrant hereby undertakes:

       (1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement: (i) to include any
prospectus required by Section 10(a)(3) of the Securities Act of 1933, as
amended (the "Securities Act"); (ii) to reflect in the prospectus any facts or
events arising after the effective date of the registration statement (or the
most recent post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth in the
registration statement; and (iii) to include any material information with
respect to the plan of distribution not previously disclosed in the registration
statement or any material change to such information in the registration
statement; provided, however, that clauses (i) and (ii) do not apply if the
information required to be included in a post-effective amendment by those
clauses is contained in periodic reports filed with or furnished to the
Securities and Exchange Commission by the Registrant pursuant to Section 13 or
Section 15(d) of the Exchange Act that are incorporated by reference in the
registration statement;

       (2) That, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof; and

       (3) To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the termination of
the offering.

B.     The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the
Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the
Exchange Act that is incorporated by reference in the registration statement
shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.

C.     Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the provisions described under Item 6 above or otherwise,
the Registrant has been advised that in the opinion of the Commission such
indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.



                                       4
<PAGE>   5


                                   SIGNATURES


         Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets all
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Dublin, State of Ohio, on the 30th day of May, 2000.



                                              CARDINAL HEALTH, INC.


                                              By: /s/ Robert D. Walter
                                                  --------------------
                                                  Robert D. Walter, Chairman
                                                  and Chief Executive Officer


         Each of the undersigned officers and directors of Cardinal Health,
Inc., an Ohio corporation (the "Company"), which proposes to file with the
Securities and Exchange Commission a Registration Statement on Form S-8 under
the Securities Act of 1933, as amended, hereby constitutes and appoints Robert
D. Walter, Steven Alan Bennett, and Brendan A. Ford and each of them, severally,
as his/her attorney-in-fact and agent, with full power of substitution and
resubstitution, in his/her name and on his/her behalf, to sign in any and all
capacities such Registration Statement and any and all amendments (including
pre- or post-effective amendments) and exhibits thereto, and any and all
applications and other documents relating thereto, with full power and authority
to perform and do any and all acts and things whatsoever which any such attorney
or substitute may deem necessary or advisable to be performed or done in
connection with any or all of the above-described matters, as fully as each of
the undersigned could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute. This Power of Attorney
has been signed in the respective capacities and on the respective dates
indicated below.

         Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities indicated on the 30th day of May, 2000.


Signature                          Title
---------                          -----




/s/ Robert D. Walter               Chairman, Chief Executive Officer
--------------------               and Director (principal executive officer)
Robert D. Walter


/s/ Richard J. Miller              Executive Vice President and Chief
---------------------              Financial Officer (principal financial
Richard J. Miller                  officer)


/s/ Michael E. Beaulieu            Senior Vice President, Controller and
-----------------------            Principal Accounting Officer (principal
Michael E. Beaulieu                accounting officer)





                                       5
<PAGE>   6





/s/ Silas S. Cathcart              Director
-------------------------
Silas S. Cathcart


/s/ George H. Conrades             Director
----------------------
George H. Conrades


/s/ John F. Finn                   Director
-------------------------
John F. Finn


/s/ Robert L. Gerbig               Director
-------------------------
Robert L. Gerbig


/s/ John F. Havens                 Director
-------------------------
John F. Havens


/s/ Regina E. Herzlinger           Director
-------------------------
Regina E. Herzlinger


/s/ John C. Kane                   Director
-------------------------
John C. Kane


/s/ J. Michael Losh                Director
-------------------------
J. Michael Losh


/s/ John B. McCoy                  Director
-------------------------
John B. McCoy


/s/ Richard C. Notebaert           Director
------------------------
Richard C. Notebaert


/s/ Michael D. O'Halleran          Director
-------------------------
Michael D. O'Halleran


/s/ Melburn G. Whitmire            Director
-------------------------
Melburn G. Whitmire






                                       6
<PAGE>   7


                                  EXHIBIT INDEX
                                  -------------



EXHIBIT
NUMBER     EXHIBIT DESCRIPTION
------     -------------------

4(a)       Specimen Certificate for the Registrant's Class A Common Shares (1)

4(b)       Cardinal Health, Inc. Global Employee Stock Purchase Plan

5          Opinion of Amy B. Haynes as to legality of the Common Shares being
           registered

23(a)      Consent of Deloitte & Touche LLP

23(b)      Consent of PricewaterhouseCoopers LLP

23(c)      Consent of Arthur Andersen LLP

23(d)      Consent of Amy B. Haynes (included in Opinion filed as Exhibit 5
           hereto)

24         Power of Attorney (included in Signature Page to Registration
           Statement)

---------------


(1)        Included as an exhibit to the Registrant's Registration Statement on
           Form S-4 (No. 333-74761) and incorporated by reference.




                                       7


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission